|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Attard G, Parker C, Eeles RA, Schröder F,
Tomlins SA, Tannock I, Drake CG and de Bono JS: Prostate cancer.
Lancet. 387:70–82. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yuan X, Cai C, Chen S, Chen S, Yu Z and
Balk SP: Androgen receptor functions in castration-resistant
prostate cancer and mechanisms of resistance to new agents
targeting the androgen axis. Oncogene. 33:2815–2825. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clarke NW: Landmarks in non-hormonal
pharmacological therapies for castration-resistant prostate cancer.
BJU Int. 110 (Suppl 1):S14–S22. 2012. View Article : Google Scholar
|
|
5
|
Djebali S, Davis CA, Merkel A, Dobin A,
Lassmann T, Mortazavi A, Tanzer A, Lagarde J, Lin W, Schlesinger F,
et al: Landscape of transcription in human cells. Nature.
489:101–108. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ji P, Diederichs S, Wang W, Böing S,
Metzger R, Schneider PM, Tidow N, Brandt B, Buerger H, Bulk E, et
al: MALAT-1, a novel noncoding RNA, and thymosin beta4 predict
metastasis and survival in early-stage non-small cell lung cancer.
Oncogene. 22:8031–8041. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Amodio N, Raimondi L, Juli G, Stamato MA,
Caracciolo D, Tagliaferri P and Tassone P: MALAT1: A druggable long
non-coding RNA for targeted anti-cancer approaches. J Hematol
Oncol. 11:632018. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wu L, Wang X and Guo Y: Long non-coding
RNA MALAT1 is upregulated and involved in cell proliferation,
migration and apoptosis in ovarian cancer. Exp Ther Med.
13:3055–3060. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang L, Bai HS, Deng Y and Fan L: High
MALAT1 expression predicts a poor prognosis of cervical cancer and
promotes cancer cell growth and invasion. Eur Rev Med Pharmacol
Sci. 19:3187–3193. 2015.PubMed/NCBI
|
|
10
|
Sun R, Qin C, Jiang B, Fang S, Pan X, Peng
L, Liu Z, Li W, Li Y and Li G: Down-regulation of MALAT1 inhibits
cervical cancer cell invasion and metastasis by inhibition of
epithelial-mesenchymal transition. Mol Biosyst. 12:952–962. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Wu Z, Yuan J, Sun L, Lin L, Huang N,
Bin J, Liao Y and Liao W: Long non-coding RNA MALAT1 promotes
gastric cancer tumorigenicity and metastasis by regulating
vasculogenic mimicry and angiogenesis. Cancer Lett. 395:31–44.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ren S, Liu Y, Xu W, Sun Y, Lu J, Wang F,
Wei M, Shen J, Hou J, Gao X, et al: Long noncoding RNA MALAT-1 is a
new potential therapeutic target for castration resistant prostate
cancer. J Urol. 190:2278–2287. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Luan W, Li L, Shi Y, Bu X, Xia Y, Wang J,
Djangmah HS, Liu X, You Y and Xu B: Long non-coding RNA MALAT1 acts
as a competing endogenous RNA to promote malignant melanoma growth
and metastasis by sponging miR-22. Oncotarget. 7:63901–63912. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chou J, Wang B, Zheng T, Li X, Zheng L, Hu
J, Zhang Y, Xing Y and Xi T: MALAT1 induced migration and invasion
of human breast cancer cells by competitively binding miR-1 with
cdc42. Biochem Biophys Res Commun. 472:262–269. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jin C, Yan B, Lu Q, Lin Y and Ma L:
Reciprocal regulation of Hsa-miR-1 and long noncoding RNA MALAT1
promotes triple-negative breast cancer development. Tumour Biol.
37:7383–7394. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hudson RS, Yi M, Esposito D, Watkins SK,
Hurwitz AA, Yfantis HG, Lee DH, Borin JF, Naslund MJ, Alexander RB,
et al: MicroRNA-1 is a candidate tumor suppressor and prognostic
marker in human prostate cancer. Nucleic Acids Res. 40:3689–3703.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
van Bokhoven A, Varella-Garcia M, Korch C,
Johannes WU, Smith EE, Miller HL, Nordeen SK, Miller GJ and Lucia
MS: Molecular characterization of human prostate carcinoma cell
lines. Prostate. 57:205–225. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yoshimoto R, Mayeda A, Yoshida M and
Nakagawa S: MALAT1 long non-coding RNA in cancer. Biochim Biophys
Acta. 1859:192–199. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tripathi V, Ellis JD, Shen Z, Song DY, Pan
Q, Watt AT, Freier SM, Bennett CF, Sharma A, Bubulya PA, et al: The
nuclear-retained noncoding RNA MALAT1 regulates alternative
splicing by modulating SR splicing factor phosphorylation. Mol
Cell. 39:925–938. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Schor IE, Llères D, Risso GJ, Pawellek A,
Ule J, Lamond AI and Kornblihtt AR: Perturbation of chromatin
structure globally affects localization and recruitment of splicing
factors. PLoS One. 7:e480842012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang B, Arun G, Mao YS, Lazar Z, Hung G,
Bhattacharjee G, Xiao X, Booth CJ, Wu J, Zhang C and Spector DL:
The lncRNA Malat1 is dispensable for mouse development but its
transcription plays a cis-regulatory role in the adult. Cell Rep.
2:111–123. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang X, Hamblin MH and Yin KJ: The long
noncoding RNA Malat1: Its physiological and pathophysiological
functions. RNA Biol. 14:1705–1714. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Salmena L, Poliseno L, Tay Y, Kats L and
Pandolfi PP: A ceRNA hypothesis: The Rosetta Stone of a hidden RNA
language? Cell. 146:353–358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Humphries CL, Balcer HI, D'Agostino JL,
Winsor B, Drubin DG, Barnes G, Andrews BJ and Goode BL: Direct
regulation of Arp2/3 complex activity and function by the actin
binding protein coronin. J Cell Biol. 159:993–1004. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Vicente-Manzanares M, Webb DJ and Horwitz
AR: Cell migration at a glance. J Cell Sci. 118:4917–4919. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mataki H, Enokida H, Chiyomaru T, Mizuno
K, Matsushita R, Goto Y, Nishikawa R, Higashimoto I, Samukawa T,
Nakagawa M, et al: Downregulation of the microRNA-1/133a cluster
enhances cancer cell migration and invasion in lung-squamous cell
carcinoma via regulation of Coronin 1C. J Hum Genet. 60:53–61.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lim JP, Shyamasundar S, Gunaratne J,
Scully OJ, Matsumoto K and Bay BH: YBX1 gene silencing inhibits
migratory and invasive potential via CORO1C in breast cancer in
vitro. BMC Cancer. 17:2012017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Thal D, Xavier CP, Rosentreter A, Linder
S, Friedrichs B, Waha A, Pietsch T, Stumpf M, Noegel A and Clemen
C: Expression of coronin-3 (coronin-1C) in diffuse gliomas is
related to malignancy. J Pathol. 214:415–424. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Shang A, Yang M, Shen F, Wang J, Wei J,
Wang W, Lu W and Wang C and Wang C: MiR-1-3p suppresses the
proliferation, invasion and migration of bladder cancer cells by
up-regulating SFRP1 expression. Cell Physiol Biochem. 41:1179–1188.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang Z, Wang J, Chen Z, Wang K and Shi L:
MicroRNA-1-3p inhibits the proliferation and migration of oral
squamous cell carcinoma cells by targeting DKK1. Biochem Cell Biol.
96:355–364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Chang J, Xu W, Du X and Hou J: MALAT1
silencing suppresses prostate cancer progression by upregulating
miR-1 and downregulating KRAS. Onco Targets Ther. 11:3461–3473.
2018. View Article : Google Scholar : PubMed/NCBI
|
